TY - T1的睡眠呼吸暂停症筛查心脏failure? Not until benefit is proven! JF - European Respiratory Journal JO - Eur Respir J SP - 1073 LP - 1074 DO - 10.1183/09031936.00030507 VL - 29 IS - 6 AU - Franklin, K. A. Y1 - 2007/06/01 UR - //www.qdcxjkg.com/content/29/6/1073.abstract N2 - In the current issue of European Respiratory Journal, in a German multicentre study, Schulz et al. 1 report a high frequency of sleep apnoea in patients with congestive heart failure (CHF). They also state that obstructive sleep apnoea (OSA) is more common in patients with heart failure than previously reported. Moving into the field of cardiology, the authors suggest that sleep studies should be routinely performed in patients with CHF and left ventricular dysfunction. It is possible to investigate these patients using modern, portable, simplified recordings of breathing during sleep. However, before investigating every patient with CHF, we need to know if and how to treat these patients. What is the best therapy? What are the goals of treatment? Which criteria should be used to define central sleep apnoea in Cheyne–Stokes respiration? OSA is characterised by snoring and daytime sleepiness due to obstructions of the upper airway during sleep. It particularly occurs in overweight patients with CHF 1–3. However, these patients with heart failure have less subjective daytime sleepiness compared with individuals from a community sample, regardless of whether or not they have OSA 4. Nasal continuous positive airway pressure (CPAP) is an effective therapy for obstructive apnoeas and only … ER -